AndzonBio2 | WebDisclosure

Basculer en Français

10651	Companies
226542	Keywords
155028	Articles
119935	Press releases

Home
Companies
AndzonBio2

BRIEF

published on 05/13/2026 at 09:25, 1 month 14 days ago

AndzonBio2, University of Cambridge, and Cambridge Enterprise Collaborate on Neuroinflammation Therapeutics

Drug Discovery Collaboration Neurodegenerative Diseases Therapeutic Development Neuroinflammation
BRIEF

published on 05/13/2026 at 09:25, 1 month 14 days ago

AndzonBio2, l'Université de Cambridge et Cambridge Enterprise collaborent sur des thérapies contre la neuroinflammation.

Collaboration Maladies Neurodégénératives Développement Thérapeutique Découverte De Médicaments Neuroinflammation
PRESS RELEASE

published on 05/13/2026 at 09:20, 1 month 14 days ago

AndzonBio2, the ALBORADA Drug Discovery Institute at the University of Cambridge and Cambridge Enterprise Announce a Collaboration to Develop First-in-Class Therapeutics for Neuroinflammation
AndzonBio2 partners with ALBORADA Drug Discovery Institute and Cambridge Enterprise to develop innovative neuroinflammation therapeutics, targeting neurodegenerative diseases like Parkinson's and Alzheimer's

Therapeutics Neuroinflammation AndzonBio2 ALBORADA Drug Discovery Institute Cambridge Enterprise

Accesswire

Published on 06/27/2026 at 01:40, 13 hours 8 minutes ago

Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 14 hours 48 minutes ago

Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 15 hours 48 minutes ago

Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 15 hours 58 minutes ago

Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/26/2026 at 22:15, 16 hours 33 minutes ago

Revive Therapeutics Announces Proposed Private Placement

View all ACCESSWIRE

EQS Group

Published on 06/27/2026 at 00:05, 14 hours 42 minutes ago

EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 14 hours 43 minutes ago

Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 15 hours 12 minutes ago

Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 15 hours 12 minutes ago

EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 15 hours 20 minutes ago

EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE

Les Echos

Published on 06/26/2026 at 17:45, 21 hours 3 minutes ago

Combined General Meeting, June 25, 2026
Published on 06/26/2026 at 17:45, 21 hours 3 minutes ago

Assemblée générale mixte du 25 juin 2026
Published on 06/26/2026 at 17:45, 21 hours 3 minutes ago

Descriptif du programme de rachat d'actions
Published on 06/26/2026 at 14:44, 1 day ago

Safran information
Published on 06/26/2026 at 14:44, 1 day ago

Information Safran

View all LES ECHOS COMFI WIRE